Inventor · disambiguated record
Stephen Chris Pappas
Also filed as: PAPPAS STEPHEN · PAPPAS STEPHEN C · PAPPAS STEPHEN CHRIS
1 granted patent·21 pending applications·13 citations·filing 2001–2025
37Inventor score
Files withMALLINCKRODT PHARMACEUTICALS IRELAND LTD13MALLINCKRODT HOSPITAL PRODUCTS IP LTD5BROWN PHILIP MANTON1Mallinckrodt Hospital Products IP Unlimited Company1PAPPAS STEPHEN1
Top patents by PatentIndex Score
22 records- 0185US10335452B2Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2015·Granted Jul 2, 2019·13 cites·28 claims
- 0281US2024374674A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 0381US2024374676A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 0481US2024374675A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 0581US2024366710A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 0679US2024238364A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 0774US2023054888A1Methods and compositions for improving kidney function in patients with hepatorenal syndromeMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Application pending·0 cites
- 0870US2023108970A1Methods and compositions for improving kidney function in patients with hepatorenal syndromeMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Application pending·0 cites
- 0970US2023126586A1Methods and compositions for improving kidney function in patients with hepatorenal syndromeMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Application pending·0 cites
- 1069US2024307483A1Compositions for improving kidney function in patients with hepatorenal syndromeMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 1168US2022143132A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Application pending·0 cites
- 1267US2021290725A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2021·Application pending·0 cites
- 1365US2024156895A1Compositions for improving kidney function in patients with hepatorenal syndromeMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Application pending·0 cites
- 1465US2025276033A1Compositions for improving kidney function in patients with hepatorenal syndromeMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2025·Application pending·0 cites
- 1564US2020046798A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2019·Application pending·0 cites
- 1661US2020246418A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2020·Application pending·0 cites
- 1746US2019328831A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2019·Application pending·0 cites
- 1844US2020237856A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2020·Application pending·0 cites
- 1943US2020187682A1Dual user bed coverPAPPAS STEPHEN·Filed 2018·Application pending·0 cites
- 2039US2021128676A1Method of treating patients with hepatorenal syndrome type 1 and low mean arterial pressureMallinckrodt Hospital Products IP Unlimited Company·Filed 2020·Application pending·0 cites
- 2138US2010113530A1S1p lyase inhibitors for the treatment of cerebral malariaBROWN PHILIP MANTON·Filed 2009·Application pending·0 cites
- 2222US2001046957A1Method for treating hepatitis CFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen Chris Pappas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →